Vanguard Personalized Indexing Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $591K | Buy |
35,274
+8,192
| +30% | +$137K | 0.01% | 1122 |
|
|
2025
Q1 | $416K | Sell |
27,082
-7,625
| -22% | -$117K | 0.01% | 1194 |
|
|
2024
Q4 | $765K | Buy |
34,707
+4,132
| +14% | +$91.1K | 0.01% | 911 |
|
|
2024
Q3 | $551K | Buy |
30,575
+2,932
| +11% | +$52.8K | 0.01% | 1050 |
|
|
2024
Q2 | $449K | Buy |
27,643
+5,831
| +27% | +$94.8K | 0.01% | 1085 |
|
|
2024
Q1 | $308K | Buy |
21,812
+5,674
| +35% | +$80.1K | 0.01% | 1250 |
|
|
2023
Q4 | $168K | Buy |
16,138
+2,041
| +14% | +$21.3K | ﹤0.01% | 1434 |
|
|
2023
Q3 | $144K | Buy |
+14,097
| New | +$144K | ﹤0.01% | 1343 |
|
|
2023
Q2 | – | Sell |
-11,315
| Closed | -$100K | – | 1525 |
|
|
2023
Q1 | $100K | Buy |
11,315
+813
| +8% | +$7.2K | ﹤0.01% | 1402 |
|
|
2022
Q4 | $95.8K | Sell |
10,502
-280
| -3% | -$2.55K | ﹤0.01% | 1223 |
|
|
2022
Q3 | $87K | Buy |
+10,782
| New | +$87K | ﹤0.01% | 1178 |
|